Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.14 +0.11 (+2.61%)
As of: Sep 30, 2026 · 3:13 PM EDT

Recursion Pharmaceuticals (RXRX) Operating Margin (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) posted Operating Margin of -1759.69% for Q2 2026, down 842.94 percentage points from -916.75% a year earlier but up 225.87 percentage points from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Operating Margin (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Margin at Recursion Pharmaceuticals was -991.72%, up 14.09 percentage points year-over-year; for FY2025, it was -867.87%, down 53.77 percentage points from FY2024.

  • Annual Operating Margin has declined for three consecutive years, though with a five-year change of +1267.80 percentage points (FY2020 to FY2025).
  • In prior years, Recursion Pharmaceuticals' Operating Margin was -814.09% in FY2024 (-28.76 pp), -785.33% in FY2023 (-168.59 pp), -616.74% in FY2022 (+1179.05 pp) and -1795.79% in FY2021 (+339.88 pp).
  • Quarterly Operating Margin has run from a low of -4042.41% in Q4 2024 to a high of -304.84% in Q4 2025 over five years.
  • On a year-over-year basis, Operating Margin increased in two of the last eight quarters, with an average year-over-year change of -516.04 percentage points.
  • The strongest year-over-year quarter for Operating Margin in the past five years was Q4 2025, with a gain of 3737.57 percentage points; the weakest was Q4 2024, with a drop of 3134.05 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was -1985.55% (Q1 2026), -304.84% (Q4 2025) and -3327.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Recursion Pharmaceuticals 2.15 Bn -450.78 Mn -3.82 Mn -1,759.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,759.69%
Mar 31, 2026 -1,985.55%
Dec 31, 2025 -304.84%
Sep 30, 2025 -3,327.57%
Jun 30, 2025 -916.75%
Mar 31, 2025 -1,297.85%
Dec 31, 2024 -4,042.41%
Sep 30, 2024 -377.10%
Jun 30, 2024 -697.39%
Mar 31, 2024 -698.42%
Dec 31, 2023 -908.36%
Sep 30, 2023 -945.12%
Jun 30, 2023 -741.72%
Mar 31, 2023 -575.78%
Dec 31, 2022 -445.91%
Sep 30, 2022 -475.48%
Jun 30, 2022 -862.54%
Mar 31, 2022 -1,049.71%
Dec 31, 2021 -2,564.55%
Sep 30, 2021 -1,831.18%
API Access

Recursion Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEY